scispace - formally typeset
F

Feng Shen

Researcher at Second Military Medical University

Publications -  403
Citations -  12498

Feng Shen is an academic researcher from Second Military Medical University. The author has contributed to research in topics: Hepatocellular carcinoma & Medicine. The author has an hindex of 46, co-authored 313 publications receiving 8315 citations.

Papers
More filters
Journal ArticleDOI

Radiomics-Based Preoperative Prediction of Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma Using Contrast-Enhanced Computed Tomography

TL;DR: Investigation of the role of radiomics-based method in predicting LN metastasis for patients with intrahepatic cholangiocarcinoma found its performance was determined by discrimination, calibration, and stratification of long-term prognosis.
Journal ArticleDOI

Prognostic factors of resectable perihilar cholangiocarcinoma: a systematic review and meta-analysis of high-quality studies:

TL;DR: In this paper, the authors defined and characterized current available evidence on prognostic factors as follows: prognostic factor associated with outcome following resection of perihilar cholangiocarcinoma.
Journal ArticleDOI

Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)

TL;DR: Wang et al. as discussed by the authors proposed a new guideline for primary liver cancer in China, which aims to encourage the implementation of evidence-based practice, and improve the national average five-year survival rate for patients with liver cancer.
Journal ArticleDOI

Association between HBV Pre-S mutations and the intracellular HBV DNAs in HBsAg-positive hepatocellular carcinoma in China.

TL;DR: This study aimed to determine the clinical features and the contribution of HBV mutations to postoperative prognosis for hepatocellular carcinoma patients with HBsAg (+) in China and to disclose the virological features to implement a more clinically personalized therapy and to improve the prognosis of HCC patients.